Bio-Techne
TECH
470 hedge funds and large institutions have $13.9B invested in Bio-Techne in 2021 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 151 increasing their positions, 182 reducing their positions, and 43 closing their positions.
167% more funds holding in top 10
Funds holding in top 10: 6 → 16 (+10)
74% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 43
28% more call options, than puts
Call options by funds: $21.6M | Put options by funds: $16.8M
22% more capital invested
Capital invested by funds: $11.5B → $13.9B (+$2.47B)
7% more funds holding
Funds holding: 440 → 470 (+30)
2.43% more ownership
Funds ownership: 375.04% → 377.47% (+2.4%)
17% less repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 182
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$122M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$112M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$91.8M |
| 4 |
BlackRock
New York
|
+$82.7M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$72.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$92M |
| 2 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$79.8M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$68.7M |
| 4 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$62.6M |
| 5 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$57.3M |
TECH Hedge Fund Activity: Q1 2021 in Review
470 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2021, worth a combined $13.9B — up 22% from $11.5B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new TECH positions and 43 closed out — a net gain of 32 holders — while 151 added to existing stakes and 182 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $122M. The largest seller was Atlanta Capital Management, cutting an estimated $92M.
- 470 institutional investors held Bio-Techne (TECH) as of Q1 2021, up from 440 in Q4 2020.
- Funds reported $13.9B of Bio-Techne stock for Q1 2021, up 22% quarter-over-quarter.
- 75 funds opened new Bio-Techne positions in Q1 2021 and 43 closed out, a net change of +32 holders.
- The largest Bio-Techne buyer in Q1 2021 was Fidelity Investments, an estimated $122M added.
- The largest Bio-Techne seller in Q1 2021 was Atlanta Capital Management, an estimated $92M sold.
Based on aggregated 13F filings for Q1 2021.